Hikma Pharmaceuticals PLC (LON:HIK) Receives Average Recommendation of “Moderate Buy” from Analysts
Hikma Pharmaceuticals PLC (LON:HIK – Get Free Report) has earned a consensus rating of “Moderate Buy” from the six brokerages that are presently covering the stock, MarketBeat.com reports. Two investment analysts have rated the stock with a hold rating and four have assigned a buy rating to the company. The average 1 year price objective […]
More Stories
Reitmans Limited (TSE:RET) Senior Officer Sells C$50,000.00 in Stock
Reitmans Limited (TSE:RET – Get Free Report) Senior Officer Richard Wait sold 20,000 shares of the firm’s stock in a...
EPR Properties (NYSE:EPR) Short Interest Update
EPR Properties (NYSE:EPR – Get Free Report) was the target of a large decrease in short interest in the month...
Excellon Resources Inc. (OTCMKTS:EXNRF) Short Interest Down 11.0% in September
Excellon Resources Inc. (OTCMKTS:EXNRF – Get Free Report) was the recipient of a significant decline in short interest in September....
Bureau Veritas SA (OTCMKTS:BVRDF) Short Interest Down 10.7% in September
Bureau Veritas SA (OTCMKTS:BVRDF – Get Free Report) saw a significant decrease in short interest in the month of September....
7 Signs You’ve Found the Perfect Career Match
Everybody wants to land their dream job, but not everyone is fortunate enough to do so. With that being said,...
Bumble Inc. (NASDAQ:BMBL) Receives Consensus Rating of “Hold” from Analysts
Bumble Inc. (NASDAQ:BMBL – Get Free Report) has been assigned an average rating of “Hold” from the eighteen analysts that...